Omeros Corporation
OMER
A$6.36
Share price
8.36%
Change (1 day)
-22.54%
Change (1 year)
Categories
Revenue for Omeros Corporation (OMER)
Revenue in 2025 (TTM): N/A
In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Omeros Corporation from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2025 (TTM)  | N/A | |
| 2024 | N/A | |
| 2023 | N/A | |
| 2022 | N/A | -100% |
| 2021 | -A$0.12 Billion | -214.79% |
| 2020 | A$95.99 M | -39.89% |
| 2019 | A$0.15 B | 276.66% |
| 2018 | A$42.39 M | -48.94% |
| 2017 | A$83.03 M | 43.82% |
| 2016 | A$57.73 M | 211.35% |
| 2015 | A$18.54 M | 2715.62% |
| 2014 | A$0.65 M | -63.28% |
| 2013 | A$1.79 M | -69.05% |
| 2012 | A$5.79 M | 31.34% |
| 2011 | A$4.41 M | 112.91% |
| 2010 | A$2.07 M | 28.92% |
| 2009 | A$1.6 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | A$0.81 M | N/A | 🇺🇸 USA |
 Genetic Technologies GENE | A$26.21 M | N/A | 🇦🇺 Australia |
 Pfizer PFE | A$95.73 B | N/A | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$136.91 B | N/A | 🇺🇸 USA |